Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasha Anvari

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Multiple Sclerosis and Related Disorders|October 30, 2024
Multiple sclerosis-associated uveitis in Persian population, a multicenter studyPasha Anvari, Sahba Fekri, Alireza Hedayatfar, et al.
European Journal of Ophthalmology|July 21, 2022
Intravitreal recombinant tPA before vitrectomy for diabetic tractional retinal detachment: A randomized controlled trialKhalil Ghasemi Falavarjani, Pasha Anvari, Esrafil Shad, et al.
Scientific Reports|November 21, 2024
Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trialRamin Nourinia, Sare Safi, Mehrad Mohammadpour, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Multiple Sclerosis and Related Disorders|October 30, 2024
Multiple sclerosis-associated uveitis in Persian population, a multicenter studyPasha Anvari, Sahba Fekri, Alireza Hedayatfar, et al.
European Journal of Ophthalmology|July 21, 2022
Intravitreal recombinant tPA before vitrectomy for diabetic tractional retinal detachment: A randomized controlled trialKhalil Ghasemi Falavarjani, Pasha Anvari, Esrafil Shad, et al.
Scientific Reports|November 21, 2024
Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trialRamin Nourinia, Sare Safi, Mehrad Mohammadpour, et al.
Pageof 5